aamc.org does not support this web browser.

Advocacy & Policy

The Association of American Medical Colleges (AAMC) works with policymakers and other leaders to advance policy priorities that strengthen the nation’s health and well-being.

Through policies that affect health care delivery, research, education, health equity, and more, the federal government is a key partner in sustaining the vitality of the nation’s academic medicine ecosystem, which is essential to improving the health of all. Learn more about the AAMC’s priorities for the 118th Congress.

Supreme Court building facade in Washington, DC

AAMC Encouraged by SCOTUS Decision on Mifepristone Access

The AAMC issued a statement regarding the SCOTUS decision on a case about mifepristone access.

learn more

AAMC Policy and Priorities

microscope

Research

AAMC-member institutions endeavor to prepare a diverse medical research workforce and champion an environment where medical discovery can flourish. This strong commitment is key to innovation that benefits patients.

Explore Research Priorities

doctor in a coat

Clinical Care

AAMC-member teaching hospitals and faculty physicians cultivate and provide high-quality health care, especially for complex and vulnerable patients -- many of whom are unable to receive care elsewhere.

Explore Clinical Care Priorities

Doctor talking to mother and son at community outreach program

Investing in Healthier Communities

Academic medical centers serve at the crossroads of community health, health equity, and population health and are actively working to prevent and address persistent public health challenges.

Explore Healthier Communities

two doctors

Workforce

AAMC-member medical schools and teaching hospitals play a crucial role in preparing future physicians who help create a healthier future for all with innovative graduate medical education.

Explore Workforce Priorities

Capitol building, Washington, DC

Washington Highlights

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting academic medicine.

Subscribe to receive weekly Hill and regulatory updates to your inbox.

Subscribe

Find Advocacy & Policy Content

  • Recent
  • Relevance

Filter Results

Date
Custom Date Range
Date format: MM/DD/YYYY
Topic
51 - 60 of 92 results
FDA - Food & Drug Administration Professional Development
Washington Highlights

The AAMC provided feedback on a discussion draft of the Cures 2.0 Act and an ARPA-H request for information.

  • July 23, 2021
microscope
Testimony & Correspondence

The AAMC submitted a comment letter on July 19 to Reps. Diana DeGette and Fred Upton in response to their Cures 2.0 Act discussion draft.

  • July 19, 2021
  • PDF
Washington Highlights

The Biden administration issued an executive order on July 9 titled “Promoting Competition in the American Economy.”

  • July 16, 2021
Biden at desk signing bill
Washington Highlights

Members of Congress reintroduced a bipartisan, bicameral bill intended to overhaul the federal government’s regulation of laboratory developed tests.

  • June 25, 2021
A researcher looks through a microscope in a lab
Washington Highlights

Reps. DeGette and Upton released a draft of the Cures 2.0 Act, legislation to authorize ARPA-H and increase patient access to new therapies, on June 22.

  • June 25, 2021
Patient in wheelchair with doctors
Washington Highlights

The Drug Enforcement Administration (DEA) takes steps to approve manufacturer applications to cultivate cannabis for research.

  • May 21, 2021
two women in lab
Washington Highlights

DeGette, Upton release “Cures 2.0 concept paper” to inform follow-on legislation to 21st Century Cures.

  • May 1, 2021
Washington Highlights

The AAMC submitted comments to the HHS on regulatory relief policies during the COVID-19 pandemic that should be made permanent.

  • Jan. 8, 2021
Patient in wheelchair with doctors
Testimony & Correspondence

AAMC provides comments to HHS on regulatory changes implemented during the PHE that we support making permanent.

  • Dec. 24, 2020
  • PDF
Press Release

The AAMC issued this statement on the U.S. Food and Drug Administration’s (FDA) authorization of a vaccine to prevent COVID-19.

  • Dec. 11, 2020
A masked patient receiving an injection from a masked medical professional
The east side of the US Capitol in the early morning.

AAMC Champion of Academic Medicine Award

This award recognizes members of Congress and staff for extraordinary leadership in support of the academic medicine community.

Learn more

Advocacy Coalitions

The Ad Hoc Group for Medical Research supports enhancing the federal investment in the biomedical, behavioral, and population-based research conducted and supported by the NIH.

The GME Advocacy Coalition (GMEAC) is a group of organizations dedicated to the expansion and preservation of Medicare-supported graduate medical education.

The HPNEC advocates for continued support for the health professions and nursing workforce development programs critical to providing continued services to underserved and minority communities.

FOVA is a diverse coalition representing national academic, medical, and scientific societies; voluntary health and patient advocacy groups; and veteran-focused associations.

Questions for the Office of Government Relations?

Email Us
AAMC Action

AAMC Action – Let’s Raise Our Voices Together

We are a community of students, residents, researchers, faculty members, physicians, and others who advocate on behalf of academic medicine to improve the health of people everywhere.

Join Us